Skip to content

Clinical trials

Frontotemporal Dementia trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Frontotemporal Dementia Phase: Not applicable Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20101
20131
20154
20164
20173
20185
20193
20201
20218
20225
202312
20243
20257
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Recruiting16
Unknown status6
Active, not recruiting4
Enrolling by invitation4
Withdrawn2
Terminated1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris4
University of California, San Francisco3
University of Chicago3
University of Pennsylvania3
University of Texas at Austin3
Drexel University2
Hospital San Carlos, Madrid2
Institut National de la Santé Et de la Recherche Médicale, France2
Johns Hopkins University2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Frontotemporal Dementia64
Alzheimer Disease35
Dementia26
Lewy Body Disease19
Aphasia, Primary Progressive17
Dementia, Vascular11
Aphasia10
Cognitive Dysfunction9
Frontotemporal Lobar Degeneration8
Neurodegenerative Diseases8

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.